Form: 10-K

Annual report pursuant to Section 13 and 15(d)

October 13, 2016

Exhibit 21

 

Subsidiaries of Registrant

 

iBioDefense Biologics LLC (wholly-owned)

 

iBio Peptide Therapeutics LLC (wholly-owned)

 

iBio Manufacturing LLC (wholly-owned)

 

iBIO DO BRASIL BIOFARMACÊUTICA LTDA. (99% ownership)

 

iBio CMO LLC (70% ownership)